Bristol-Myers Squibb Company (BMY)

Home
BMY
Financials

55.45 (USD) • At close November 4, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987
Revenue Numbers are in millions	45,006	46,159	46,385	42,518	26,145	22,561	20,776	19,427	16,560	15,879	16,385	17,621	21,244	19,484	18,808	20,597	19,348	17,914	19,207	19,380	20,894	18,119	19,423	18,216	20,222	18,284	16,701	15,065	13,767	11,984	11,413	11,156	11,159	10,300	9,189	8,558	7,558
Cost of Revenue Numbers are in millions	10,693	10,137	9,940	11,773	8,078	6,547	6,066	4,946	3,909	3,932	4,619	4,610	5,598	5,277	5,140	6,396	6,218	5,956	5,928	5,989	7,592	6,388	5,575	4,013	4,861	4,231	3,873	3,446	3,189	2,794	2,721	2,562	2,684	2,630	2,460	2,299	2,141
Gross Profit Numbers are in millions	34,313	36,022	36,445	30,745	18,067	16,014	14,710	14,481	12,651	11,947	11,766	13,011	15,646	14,207	13,668	14,201	13,130	11,958	13,279	13,391	13,302	11,731	13,848	14,203	15,361	14,053	12,828	11,619	10,578	9,190	8,692	8,594	8,475	7,670	6,729	6,259	5,417
Gross Profit Ratio Numbers are in millions	0.762	0.78	0.786	0.723	0.691	0.71	0.708	0.745	0.764	0.752	0.718	0.738	0.736	0.729	0.727	0.689	0.679	0.668	0.691	0.691	0.637	0.647	0.713	0.78	0.76	0.769	0.768	0.771	0.768	0.767	0.762	0.77	0.759	0.745	0.732	0.731	0.717
Reseach & Development Expenses Numbers are in millions	9,299	9,509	10,195	11,143	6,148	6,345	6,411	4,940	5,920	4,534	3,731	3,904	3,839	3,566	3,647	3,585	3,282	3,067	2,746	2,500	2,279	2,218	2,259	1,939	1,843	1,577	1,385	1,276	1,199	1,108	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	6,372	0	0	0	0	0	162	91	160	877	165	158	4,203	3,559	4,078	4,825	4,855	4,919	5,106	5,016	4,660	3,923	3,903	3,860	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	1,400	7,814	7,690	7,661	4,871	4,551	4,687	4,911	4,841	4,822	4,939	5,017	957	977	1,136	1,550	1,465	1,351	1,476	1,411	1,416	1,295	1,433	1,672	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	7,772	7,814	7,690	7,661	4,871	4,551	4,849	5,002	5,001	5,699	5,104	5,175	5,160	4,536	5,214	6,375	6,320	6,270	6,582	6,427	6,076	5,218	5,336	5,532	6,987	6,730	6,414	5,871	5,316	4,533	5,981	6,339	5,463	5,037	5,450	4,304	3,789
Other Expenses Numbers are in millions	1,382	9,595	10,023	9,764	1,135	1,372	1,404	1,001	621	313	133	245	0	284	-931	0	0	0	0	0	0	0	0	746	678	625	591	519	448	328	308	295	246	244	196	185	161
Operating Expenses Numbers are in millions	26,118	26,918	27,908	28,568	12,154	10,896	11,260	9,942	10,921	10,233	8,835	9,079	8,611	7,707	8,861	8,480	9,602	9,337	9,328	8,927	8,355	7,436	7,595	8,217	9,508	8,932	8,390	7,666	6,963	5,969	6,289	6,634	5,709	5,281	5,646	4,489	3,950
Operating Income Numbers are in millions	17,242	10,328	10,159	5,128	5,464	5,118	3,450	4,539	1,730	1,714	2,931	3,932	6,647	5,605	5,738	4,241	3,528	2,621	3,951	4,464	4,947	4,295	6,253	5,986	5,853	5,121	4,438	3,953	3,615	3,221	2,403	1,960	2,766	2,389	1,083	1,770	1,467
Operating Income Ratio Numbers are in millions	0.383	0.224	0.219	0.121	0.209	0.227	0.166	0.234	0.104	0.108	0.179	0.223	0.313	0.288	0.305	0.206	0.182	0.146	0.206	0.23	0.237	0.237	0.322	0.329	0.289	0.28	0.266	0.262	0.263	0.269	0.211	0.176	0.248	0.232	0.118	0.207	0.194
Total Other Income Expenses Net Numbers are in millions	1,411	-2,615	-2,061	-11,999	-489	1,075	1,877	1,543	621	870	159	-1,410	45	-359	925	-250	187	238	766	159	-41	-1,365	-3,218	-557	-63	-786	56	43	-1,255	-722	225	76	177	192	257	192	213
Income Before Tax Numbers are in millions	8,440	7,713	8,098	-6,871	4,975	6,010	5,131	5,915	2,167	2,381	2,891	2,340	6,981	6,071	5,602	5,471	3,534	2,635	4,516	4,418	4,694	2,647	2,896	5,478	5,767	4,268	4,482	4,013	2,402	2,555	2,571	1,987	2,887	2,524	1,277	1,889	1,628
Income Before Tax Ratio Numbers are in millions	0.188	0.167	0.175	-0.162	0.19	0.266	0.247	0.304	0.131	0.15	0.176	0.133	0.329	0.312	0.298	0.266	0.183	0.147	0.235	0.228	0.225	0.146	0.149	0.301	0.285	0.233	0.268	0.266	0.174	0.213	0.225	0.178	0.259	0.245	0.139	0.221	0.215
Income Tax Expense Numbers are in millions	400	1,368	1,084	2,124	1,515	1,031	4,156	1,408	477	352	311	-161	1,721	1,558	1,182	1,320	803	610	932	1,519	1,215	435	459	1,382	1,600	1,127	1,277	1,163	590	713	612	449	831	776	530	635	560
Net Income Numbers are in millions	8,025	6,327	6,994	-8,995	3,439	4,952	1,007	4,457	1,624	2,004	2,563	1,960	3,709	3,102	10,612	5,247	2,165	1,585	3,000	2,388	3,106	2,066	5,245	4,711	4,167	3,141	3,205	2,850	1,812	1,842	1,959	1,962	2,056	1,748	747	1,254	1,068
Net Income Ratio Numbers are in millions	0.178	0.137	0.151	-0.212	0.132	0.219	0.048	0.229	0.098	0.126	0.156	0.111	0.175	0.159	0.564	0.255	0.112	0.088	0.156	0.123	0.149	0.114	0.27	0.259	0.206	0.172	0.192	0.189	0.132	0.154	0.172	0.176	0.184	0.17	0.081	0.147	0.141
EPS Numbers are in millions	3.88	2.97	3.15	-3.98	2.02	3.03	0.61	2.67	0.97	1.21	1.56	1.17	2.18	1.81	5.38	2.65	1.1	0.81	1.54	1.23	1.6	1.03	2.7	2.4	2.1	1.58	1.61	1.42	0.9	0.9	0.95	0.96	0.99	0.84	0.36	0.6	0.5
EPS Diluted Numbers are in millions	3.86	2.95	3.12	-3.98	2.01	3.03	0.61	2.65	0.97	1.2	1.54	1.16	2.16	1.8	5.37	2.62	1.09	0.81	1.51	1.21	1.59	1.02	2.67	2.36	2.06	1.55	1.57	1.4	0.89	0.9	0.95	0.96	0.99	0.84	0.36	0.6	0.5
EBITDA Numbers are in millions	19,177	19,923	20,182	14,816	6,599	6,071	5,718	5,617	2,434	2,134	3,230	4,360	7,126	6,575	4,311	5,971	4,757	3,784	4,448	5,487	5,928	6,395	10,252	7,289	6,594	6,532	4,973	4,429	5,318	4,271	2,486	2,179	2,835	2,441	1,022	1,763	1,415
EBITDA Ratio Numbers are in millions	0.426	0.432	0.435	0.348	0.252	0.269	0.275	0.289	0.147	0.134	0.197	0.247	0.335	0.337	0.229	0.29	0.246	0.211	0.232	0.283	0.284	0.353	0.528	0.4	0.326	0.357	0.298	0.294	0.386	0.356	0.218	0.195	0.254	0.237	0.111	0.206	0.187

Bristol-Myers Squibb Company

NYSE:BMY Add to watchlist

NYSE:BMY